Buy Like Buffett
Watchlist

Flagship explainer

How OrthoPediatrics Corp makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$236M · 100%Cost of revenue$63.7M · 27%Gross profit$173M · 73%Operating income−$39.2M · −17%Income before tax−$39.2M · −17%Income tax$460000 · 0%Net income−$39.6M · −17%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$236M100%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
Cost of revenue$63.7M27%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
$173M73%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
−$39.2M−17%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
Income before tax−$39.2M−17%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
Income tax$4600000%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
−$39.6M−17%
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001425450-26-000013 · filed Mar 4, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full OrthoPediatrics Corp analysis at Buy Like Buffett